Are Selective Serotonin Reuptake Inhibitors Associated With Greater Apathy in Parkinson’s Disease?
Laura B. Zahodne, Ph.D.; Oscar Bernal-Pacheco, M.D.; Dawn Bowers, Ph.D.; Herbert Ward, M.D.; Genko Oyama, M.D.; Natlada Limotai, M.D.; Frances Velez-Lago, M.D.; Ramon L. Rodriguez, M.D.; Irene Malaty, M.D.; Nikolaus R. McFarland, M.D., Ph.D.; Michael S. Okun, M.D.
From the Dept of Neurology, Center for Movement Disorders and Neuro-restoration, University of Florida, Gainesville, FL (OB-P, DB, GO, NL, FV-L, RLR, IM, NRM, MSO); the Dept. of Clinical and Health Psychology, Center for Movement Disorders and Neuro-restoration, University of Florida, Gainesville, FL (LBZ, DB); the Dept. of Psychiatry, Center for Movement Disorders and Neuro-restoration University of Florida, Gainesville, FL (HW); and the Dept. of Neurosurgery, Center for Movement Disorders and Neuro-restoration, University of Florida, Gainesville, FL (MSO).
The Journal of Neuropsychiatry and Clinical Neurosciences 2012;24:326-330.
doi:10.1176/appi.neuropsych.11090210
Purchase Online access to this article for 24 hours
Clicking on the buy now link will redirect you to the shopping cart at APPI.org where you will be asked to log in or create an account to complete your transaction. Once your transaction is complete, you will receive an email with instructions for accessing this content online and in PDF format.
You may view, download, and/or print the article for your personal, scholarly, research, and educational use. You may not (i) distribute a copy
(electronic or otherwise) of the article without the written permission of APA, (ii) post the article on an electronic bulletin board or web
site, or (iii) charge for a copy (electronic or otherwise) of the article.